{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:09:30Z","timestamp":1789456170874,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["2039\/20 and 231\/21"],"award-info":[{"award-number":["2039\/20 and 231\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HI-TRON seed funding program 2021","award":["2021"],"award-info":[{"award-number":["2021"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["439669440 TRR319 RMaP TP A04"],"award-info":[{"award-number":["439669440 TRR319 RMaP TP A04"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DKFZ-Hector Seed Funding","award":["Project \"ENIGMA\""],"award-info":[{"award-number":["Project \"ENIGMA\""]}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["Core Funding DKFZ"],"award-info":[{"award-number":["Core Funding DKFZ"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Neoepitope-based therapies hold great promise for cancer immunotherapy because they target tumor-specific mutations and elicit potent anti-tumor T-cell responses. However, their clinical implementation remains limited by the complexity of neoepitope discovery and uncertainty regarding presentation by tumor cells. A potential alternative is the generation of immunogenic neoepitopes directly within cancer cells through programmable RNA editing. Here, we develop Short Precise-Encodable ADAR Recruiting (SPEAR) gRNAs that harness endogenous ADAR1 to direct precise adenosine-to-inosine (A-to-I) editing at selected transcript sites. Using these gRNAs, we demonstrate the generation of immunogenic neoepitopes through RNA editing at the transcript level, termed\n                    <jats:italic>editopes<\/jats:italic>\n                    . In a proof-of-concept model based on the melanoma antigen MART-1, SPEAR-mediated RNA editing restored antigen-specific T\u00a0cell recognition and enabled tumor control in vivo. Finally, we developed a computational pipeline to identify candidate tumor-selective neoepitopes across multiple cancer types amenable to guided RNA editing. Our findings establish programmable RNA editing as a strategy for engineering immunogenic editopes and provide a framework for neoepitope-directed cancer immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s44318-026-00870-5","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:58:44Z","timestamp":1786694324000},"page":"6655-6678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering editopes through programmable RNA editing toward tumor neoantigen generation"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9052-4075","authenticated-orcid":false,"given":"Riccardo","family":"Pecori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8516-5792","authenticated-orcid":false,"given":"Beatrice","family":"Casati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-8158","authenticated-orcid":false,"given":"Rona","family":"Merdler-Rabinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5050-4861","authenticated-orcid":false,"given":"Netanel","family":"Landesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khwab","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-9652","authenticated-orcid":false,"given":"Stefan","family":"Zens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8976-2929","authenticated-orcid":false,"given":"Ece","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2011-8345","authenticated-orcid":false,"given":"Mantiana","family":"Topouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kipfstuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5253-095X","authenticated-orcid":false,"given":"Veronica","family":"Pinamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-7036","authenticated-orcid":false,"given":"Mohammad","family":"Abukhalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9467-1213","authenticated-orcid":false,"given":"David","family":"Gomez-Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-0017","authenticated-orcid":false,"given":"Stefan","family":"Tenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4940-5354","authenticated-orcid":false,"given":"John M","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Platten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rienk","family":"Offringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-829X","authenticated-orcid":false,"given":"Rafael","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7862-3940","authenticated-orcid":false,"given":"Eytan","family":"Ruppin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-4198","authenticated-orcid":false,"given":"Erez Y","family":"Levanon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-7909","authenticated-orcid":false,"given":"Fotini Nina","family":"Papavasiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.omtn.2019.12.042","volume":"19","author":"G Aquino-Jarquin","year":"2020","unstructured":"Aquino-Jarquin G (2020) Novel engineered programmable systems for ADAR-mediated RNA editing. Mol Ther Nucleic Acids 19:1065\u20131072","journal-title":"Mol Ther Nucleic Acids"},{"key":"870_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-1-7","volume":"1","author":"H Arakawa","year":"2001","unstructured":"Arakawa H, Lodygin D, Buerstedde JM (2001) Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol 1:7","journal-title":"BMC Biotechnol"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1073\/pnas.48.4.613","volume":"48","author":"C Basilio","year":"1962","unstructured":"Basilio C, Wahba AJ, Lengyel P, Speyer JF, Ochoa S (1962) Synthetic polynucleotides and the amino acid code, V. Proc Natl Acad Sci USA 48:613\u2013616","journal-title":"Proc Natl Acad Sci USA"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S, Caux C, Depil S (2019) Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol 10:168","journal-title":"Front Immunol"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ymthe.2023.01.005","volume":"31","author":"BJ Booth","year":"2023","unstructured":"Booth BJ, Nourreddine S, Katrekar D, Savva Y, Bose D, Long TJ, Huss DJ, Mali P (2023) RNA editing: Expanding the potential of RNA therapeutics. Mol Ther 31:1533\u20131549","journal-title":"Mol Ther"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1021\/acs.analchem.1c03782","volume":"94","author":"A Brzhozovskiy","year":"2022","unstructured":"Brzhozovskiy A, Kononikhin A, Bugrova AE, Kovalev GI, Schmit P-O, Kruppa G, Nikolaev EN, Borchers CH (2022) The parallel reaction monitoring-parallel accumulation\u2013serial fragmentation (prm-PASEF) approach for multiplexed absolute quantitation of proteins in human plasma. Anal Chem 94:2016\u20132022","journal-title":"Anal Chem"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611\u2013622","journal-title":"Clin Chem"},{"key":"870_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60155-z","volume":"16","author":"SM Byrne","year":"2025","unstructured":"Byrne SM, Burleigh SM, Fragoza R, Jiang Y, Savva Y, Pabon R, Kania E, Rainaldi J, Portell A, Mali P et al (2025) An engineered U7 small nuclear RNA scaffold greatly increases ADAR-mediated programmable RNA base editing. Nat Commun 16:4860","journal-title":"Nat Commun"},{"key":"870_CR9","doi-asserted-by":"crossref","unstructured":"Casati B, Stamkopoulou D, Tasakis RN, Pecori R (2021) ADAR-mediated RNA editing and its therapeutic potentials. In: Jurga S, Barciszewski J (eds) Epitranscriptomics. Springer, pp 471\u2013503","DOI":"10.1007\/978-3-030-71612-7_18"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ijc.27675","volume":"132","author":"F Castro","year":"2013","unstructured":"Castro F, Dirks WG, F\u00e4hnrich S, Hotz-Wagenblatt A, Pawlita M, Schmitt M (2013) High-throughput SNP-based authentication of human cell lines. Int J Cancer 132:308\u2013314","journal-title":"Int J Cancer"},{"key":"870_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk3060","volume":"10","author":"M Cetin","year":"2024","unstructured":"Cetin M, Pinamonti V, Schmid T, Boschert T, Mellado Fuentes A, Kromer K, Lerner T, Zhang J, Herzig Y, Ehlert C et al (2024) T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery. Sci Adv 10:eadk3060","journal-title":"Sci Adv"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41586-024-07797-z","volume":"633","author":"ASL Chan","year":"2024","unstructured":"Chan ASL, Zhu H, Narita M, Cassidy LD, Young ARJ, Bermejo-Rodriguez C, Janowska AT, Chen H-C, Gough S, Oshimori N et al (2024) Titration of RAS alters senescent state and influences tumour initiation. Nature 633:678\u2013685","journal-title":"Nature"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","volume":"30","author":"TA Chan","year":"2019","unstructured":"Chan TA, Yarchoan M, Jaffee E, Swanton C, Quezada SA, Stenzinger A, Peters S (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol 30:44\u201356","journal-title":"Ann Oncol"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement K, Rees H, Canver MC, Gehrke JM, Farouni R, Hsu JY, Cole MA, Liu DR, Joung JK, Bauer DE et al (2019) CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat Biotechnol 37:224\u2013226","journal-title":"Nat Biotechnol"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.180.1.35","volume":"180","author":"PG Coulie","year":"1994","unstructured":"Coulie PG, Brichard V, Van Pel A, W\u00f6lfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP et al (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35\u201342","journal-title":"J Exp Med"},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0022-2836(02)00237-1","volume":"318","author":"Z Cui","year":"2002","unstructured":"Cui Z, Geurts AM, Liu G, Kaufman CD, Hackett PB (2002) Structure\u2013function analysis of the inverted terminal repeats of the Sleeping Beauty transposon. J Mol Biol 318:1221\u20131235","journal-title":"J Mol Biol"},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"818619","DOI":"10.3389\/fbinf.2022.818619","volume":"2","author":"MW Davis","year":"2022","unstructured":"Davis MW, Jorgensen EM (2022) ApE, a plasmid editor: a freely available DNA manipulation and visualization program. Front Bioinform 2:818619","journal-title":"Front Bioinform"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-18-0573","volume":"24","author":"DC Deniger","year":"2018","unstructured":"Deniger DC, Pasetto A, Robbins PF, Gartner JJ, Prickett TD, Paria BC, Malekzadeh P, Jia L, Yossef R, Langhan MM et al (2018) T-cell responses to TP53 \u2018hotspot\u2019 mutations and unique neoantigens expressed by human ovarian cancers. Clin Cancer Res 24:5562\u20135573","journal-title":"Clin Cancer Res"},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman JL, Raguram A, Newby GA, Liu DR (2020) Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol 38:620\u2013628","journal-title":"Nat Biotechnol"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.3747\/co.27.5223","volume":"27","author":"K Esfahani","year":"2020","unstructured":"Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja N, Miller WH (2020) A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol 27:S87\u2013S97","journal-title":"Curr Oncol"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822\u2013826","journal-title":"Nat Biotechnol"},{"key":"870_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0065-230X(01)83005-0","volume":"83","author":"F Garrido","year":"2001","unstructured":"Garrido F, Algarra I (2001) MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 83:117\u2013158","journal-title":"Adv Cancer Res"},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s43018-021-00197-6","volume":"2","author":"JJ Gartner","year":"2021","unstructured":"Gartner JJ, Parkhurst MR, Gros A, Tran E, Jafferji MS, Copeland A, Hanada K-I, Zacharakis N, Lalani A, Krishna S et al (2021) A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types. Nat Cancer 2:563\u2013574","journal-title":"Nat Cancer"},{"key":"870_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46380-y","volume":"15","author":"D Gomez-Zepeda","year":"2024","unstructured":"Gomez-Zepeda D, Arnold-Schild D, Beyrle J, Declercq A, Gabriels R, Kumm E, Preikschat A, \u0141\u0105cki MK, Hirschler A, Rijal JB et al (2024) Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS2Rescore with MS2PIP timsTOF fragmentation prediction model. Nat Commun 15:2288","journal-title":"Nat Commun"},{"key":"870_CR25","doi-asserted-by":"crossref","unstructured":"Gomez-Zepeda D, Beyrle J, Preikschat A, Declercq A, Chen Y, Gabriels R, Martens L, Distler U, Tenzer S (2026) High-coverage immunopeptidomics using timsTOF mass spectrometers with thunder-DDA-PASEF boosted by MS2Rescore. In: Fulton KM, Twine SM (eds). Immunoproteomics: methods and protocols. Springer, NewYork, pp 115\u2013155","DOI":"10.1007\/978-1-0716-4832-2_5"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman RL, Heath AP, Ferretti V, Varmus HE, Lowy DR, Kibbe WA, Staudt LM (2016) Toward a shared vision for cancer genomic data. N Engl J Med 375:1109\u20131112","journal-title":"N Engl J Med"},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/ijc.22584","volume":"120","author":"D Ito","year":"2007","unstructured":"Ito D, Visus C, Hoffmann TK, Balz V, Bier H, Appella E, Whiteside TL, Ferris RL, DeLeo AB (2007) Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck. Int J Cancer 120:2618\u20132624","journal-title":"Int J Cancer"},{"key":"870_CR28","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.4049\/jimmunol.177.9.6548","volume":"177","author":"LA Johnson","year":"2006","unstructured":"Johnson LA, Heemskerk B, Powell DJ, Cohen CJ, Morgan RA, Dudley ME, Robbins PF, Rosenberg SA (2006) Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J Immunol 177:6548\u20136559","journal-title":"J Immunol"},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41592-019-0323-0","volume":"16","author":"D Katrekar","year":"2019","unstructured":"Katrekar D, Chen G, Meluzzi D, Ganesh A, Worlikar A, Shih Y-R, Varghese S, Mali P (2019) In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nat Methods 16:239\u2013242","journal-title":"Nat Methods"},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41587-021-01171-4","volume":"40","author":"D Katrekar","year":"2022","unstructured":"Katrekar D, Yen J, Xiang Y, Saha A, Meluzzi D, Savva Y, Mali P (2022) Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs. Nat Biotechnol 40:938\u2013945","journal-title":"Nat Biotechnol"},{"key":"870_CR32","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","volume":"91","author":"Y Kawakami","year":"1994","unstructured":"Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515\u20133519","journal-title":"Proc Natl Acad Sci USA"},{"key":"870_CR33","doi-asserted-by":"crossref","unstructured":"Kluesner M, Tasakis RN, Lerner T, Arnold A, W\u00fcst S, Binder M, Webber BR, Moriarity BS, Pecori R (2021) MultiEditR: the first tool for detection and quantification of multiple RNA editing sites from Sanger sequencing demonstrates comparable fidelity to RNA-seq. Mol Ther Nucleic Acids 25:515\u2013523","DOI":"10.1016\/j.omtn.2021.07.008"},{"key":"870_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/nar\/gky1163","volume":"47","author":"K Licht","year":"2019","unstructured":"Licht K, Hartl M, Amman F, Anrather D, Janisiw MP, Jantsch MF (2019) Inosine induces context-dependent recoding and translational stalling. Nucleic Acids Res 47:3\u201314","journal-title":"Nucleic Acids Res"},{"key":"870_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02460-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Chen O, Wall JBJ, Zheng M, Zhou Y, Wang L, Ruth Vaseghi H, Qian L, Liu J (2017) Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci Rep 7:2193","journal-title":"Sci Rep"},{"key":"870_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"870_CR37","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","volume":"184","author":"SX Lu","year":"2021","unstructured":"Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, Knorr DA, Greenbaum B, Elhanati Y, Hogg SJ et al (2021) Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 184:4032\u20134047.e31","journal-title":"Cell"},{"key":"870_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41587-019-0013-6","volume":"37","author":"T Merkle","year":"2019","unstructured":"Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P, Wettengel J, Li JB, Stafforst T (2019) Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat Biotechnol 37:133\u2013138","journal-title":"Nat Biotechnol"},{"key":"870_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41587-022-01225-1","volume":"40","author":"P Monian","year":"2022","unstructured":"Monian P, Shivalila C, Lu G, Shimizu M, Boulay D, Bussow K, Byrne M, Bezigian A, Chatterjee A, Chew D et al (2022) Endogenous ADAR-mediated RNA editing in non-human primates using stereopure chemically modified oligonucleotides. Nat Biotechnol 40:1093\u20131102","journal-title":"Nat Biotechnol"},{"key":"870_CR40","first-page":"e157","volume":"44","author":"MF Montiel-Gonz\u00e1lez","year":"2016","unstructured":"Montiel-Gonz\u00e1lez MF, Vallecillo-Viejo IC, Rosenthal JJC (2016) An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res 44:e157","journal-title":"Nucleic Acids Res"},{"key":"870_CR41","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-22-1525","volume":"82","author":"R Nagel","year":"2022","unstructured":"Nagel R, Pataskar A, Champagne J, Agami R (2022) Boosting antitumor immunity with an expanded neoepitope landscape. Cancer Res 82:3637\u20133649","journal-title":"Cancer Res"},{"key":"870_CR42","doi-asserted-by":"publisher","first-page":"D462","DOI":"10.1093\/nar\/gkae1032","volume":"53","author":"S Okuda","year":"2025","unstructured":"Okuda S, Yoshizawa AC, Kobayashi D, Takahashi Y, Watanabe Y, Moriya Y, Hatano A, Takami T, Matsumoto M, Araki N et al (2025) jPOST environment accelerates the reuse and reanalysis of public proteome mass spectrometry data. Nucleic Acids Res 53:D462\u2013D467","journal-title":"Nucleic Acids Res"},{"key":"870_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.celrep.2015.08.080","volume":"13","author":"N Paz-Yaacov","year":"2015","unstructured":"Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E, Levanon EY (2015) Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep 13:267\u2013276","journal-title":"Cell Rep"},{"key":"870_CR44","doi-asserted-by":"publisher","first-page":"1080626","DOI":"10.3389\/fcell.2022.1080626","volume":"10","author":"R Pecori","year":"2023","unstructured":"Pecori R, Chill\u00f3n I, Lo Giudice C, Arnold A, W\u00fcst S, Binder M, Marcia M, Picardi E, Papavasiliou FN (2023) ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts. Front Cell Dev Biol 10:1080626","journal-title":"Front Cell Dev Biol"},{"key":"870_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jim.2014.01.012","volume":"405","author":"JK Peper","year":"2014","unstructured":"Peper JK, Schuster H, L\u00f6ffler MW, Schmid-Horch B, Rammensee H-G, Stevanovi\u0107 S (2014) An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells. J Immunol Methods 405:192\u2013198","journal-title":"J Immunol Methods"},{"key":"870_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mas.21540","volume":"39","author":"LK Pino","year":"2020","unstructured":"Pino LK, Searle BC, Bollinger JG, Nunn B, MacLean B, MacCoss MJ (2020) The Skyline ecosystem: informatics for quantitative mass spectrometry proteomics. Mass Spectrom Rev 39:229\u2013244","journal-title":"Mass Spectrom Rev"},{"key":"870_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1315-y","volume":"18","author":"HT Porath","year":"2017","unstructured":"Porath HT, Knisbacher BA, Eisenberg E, Levanon EY (2017) Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance. Genome Biol 18:185","journal-title":"Genome Biol"},{"key":"870_CR48","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","volume":"37","author":"L Qu","year":"2019","unstructured":"Qu L, Yi Z, Zhu S, Wang C, Cao Z, Zhou Z, Yuan P, Yu Y, Tian F, Liu Z et al (2019) Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs. Nat Biotechnol 37:1059\u20131069","journal-title":"Nat Biotechnol"},{"key":"870_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2014-04-567933","volume":"124","author":"M Rajasagi","year":"2014","unstructured":"Rajasagi M, Shukla SA, Fritsch EF, Keskin DB, DeLuca D, Carmona E, Zhang W, Sougnez C, Cibulskis K, Sidney J et al (2014) Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. Blood 124:453\u2013462","journal-title":"Blood"},{"key":"870_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41587-024-02313-0","volume":"43","author":"P Reautschnig","year":"2025","unstructured":"Reautschnig P, Fruhner C, Wahn N, Wiegand CP, Kragness S, Yung JF, Hofacker DT, Fisk J, Eidelman M, Waffenschmidt N et al (2025) Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA. Nat Biotechnol 43:545\u2013557","journal-title":"Nat Biotechnol"},{"key":"870_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41587-021-01105-0","volume":"40","author":"P Reautschnig","year":"2022","unstructured":"Reautschnig P, Wahn N, Wettengel J, Schulz AE, Latifi N, Vogel P, Kang T-W, Pfeiffer LS, Zarges C, Naumann U et al (2022) CLUSTER guide RNAs enable precise and efficient RNA editing with endogenous ADAR enzymes in vivo. Nat Biotechnol 40:759\u2013768","journal-title":"Nat Biotechnol"},{"key":"870_CR52","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Alvarez B, Paul S, Peters B, Nielsen M (2020) NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res 48:W449\u2013W454","journal-title":"Nucleic Acids Res"},{"key":"870_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A et al (2023) Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618:144\u2013150","journal-title":"Nature"},{"key":"870_CR54","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","volume":"51","author":"RM Samstein","year":"2019","unstructured":"Samstein RM, Lee C-H, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A et al (2019) Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51:202\u2013206","journal-title":"Nat Genet"},{"key":"870_CR55","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1093\/nar\/gkp581","volume":"37","author":"M Schmitt","year":"2009","unstructured":"Schmitt M, Pawlita M (2009) High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 37:e119","journal-title":"Nucleic Acids Res"},{"key":"870_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher TN, Schreiber RD (2015) Neoantigens in cancer immunotherapy. Science 348:69\u201374","journal-title":"Science"},{"key":"870_CR57","doi-asserted-by":"crossref","unstructured":"Smargon AA, Pant D, Gomberg TA, Fagre C, Glynne S, Nguyen J, Naritomi JT, Gilbert WV, Yeo GW (2025) Enhancing RNA base editing on mammalian transcripts with small nuclear RNAs. Nat Chem Biol 22:995\u20131003","DOI":"10.1038\/s41589-025-02026-8"},{"key":"870_CR58","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nbt.4239","volume":"36","author":"AC Smart","year":"2018","unstructured":"Smart AC, Margolis CA, Pimentel H, He MX, Miao D, Adeegbe D, Fugmann T, Wong KK, Allen EMV (2018) Intron retention is a source of neoepitopes in cancer. Nat Biotechnol 36:1056\u20131058","journal-title":"Nat Biotechnol"},{"key":"870_CR59","doi-asserted-by":"crossref","unstructured":"Sun Y, Cao Y, Song Y, Li J, Hou Y, Huang W, Xie G, Yang W, Zhang R (2025) Improved RNA base editing with guide RNAs mimicking highly edited endogenous ADAR substrates. Nat Biotechnol 44:464\u2013476","DOI":"10.1038\/s41587-025-02628-6"},{"key":"870_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature24041","volume":"550","author":"MH Tan","year":"2017","unstructured":"Tan MH, Li Q, Shanmugam R, Piskol R, Kohler J, Young AN, Liu KI, Zhang R, Ramaswami G, Ariyoshi K et al (2017) Dynamic landscape and regulation of RNA editing in mammals. Nature 550:249\u2013254","journal-title":"Nature"},{"key":"870_CR61","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.molcel.2021.03.024","volume":"81","author":"A Uzonyi","year":"2021","unstructured":"Uzonyi A, Nir R, Shliefer O, Stern-Ginossar N, Antebi Y, Stelzer Y, Levanon EY, Schwartz S (2021) Deciphering the principles of the RNA editing code via large-scale systematic probing. Mol Cell 81:2374\u20132387.e3","journal-title":"Mol Cell"},{"key":"870_CR62","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","volume":"160","author":"D Valmori","year":"1998","unstructured":"Valmori D, Fonteneau JF, Lizana CM, Gervois N, Li\u00e9nard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P (1998) Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues. J Immunol 160:1750\u20131758","journal-title":"J Immunol"},{"key":"870_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nbt.2839","volume":"32","author":"JA Vizca\u00edno","year":"2014","unstructured":"Vizca\u00edno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, R\u00edos D, Dianes JA, Sun Z, Farrah T, Bandeira N et al (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32:223\u2013226","journal-title":"Nat Biotechnol"},{"key":"870_CR64","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.copbio.2018.08.006","volume":"55","author":"P Vogel","year":"2018","unstructured":"Vogel P, Stafforst T (2018) Critical review on engineering deaminases for site-directed RNA editing. Curr Opin Biotechnol 55:74\u201380","journal-title":"Curr Opin Biotechnol"},{"key":"870_CR65","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton RT, Christie KA, Whittaker MN, Kleinstiver BP (2020) Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368:290\u2013296","journal-title":"Science"},{"key":"870_CR66","first-page":"2797","volume":"45","author":"J Wettengel","year":"2017","unstructured":"Wettengel J, Reautschnig P, Geisler S, Kahle PJ, Stafforst T (2017) Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic acids Res 45:2797\u20132808","journal-title":"Nucleic acids Res"},{"key":"870_CR67","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM (2017) Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med 377:2500\u20132501","journal-title":"N Engl J Med"},{"key":"870_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012) Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinforma 13:134","journal-title":"BMC Bioinforma"},{"key":"870_CR69","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41587-021-01180-3","volume":"40","author":"Z Yi","year":"2022","unstructured":"Yi Z, Qu L, Tang H, Liu Z, Liu Y, Tian F, Wang C, Zhang X, Feng Z, Yu Y et al (2022) Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo. Nat Biotechnol 40:946\u2013955","journal-title":"Nat Biotechnol"},{"key":"870_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39869-5","volume":"14","author":"F Yu","year":"2023","unstructured":"Yu F, Teo GC, Kong AT, Fr\u00f6hlich K, Li GX, Demichev V, Nesvizhskii AI (2023) Analysis of DIA proteomics data using MSFragger-DIA and FragPipe computational platform. Nat Commun 14:4154","journal-title":"Nat Commun"},{"key":"870_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06405-9","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang M, Fritsche J, Roszik J, Williams LJ, Peng X, Chiu Y, Tsou CC, Hoffgaard F, Goldfinger V, Schoor O et al (2018) RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat Commun 9:3919","journal-title":"Nat Commun"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00870-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:33:30Z","timestamp":1789454010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00870-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":70,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9,15]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00870-5","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RP and AA are inventors on a patent application related to the design of ADAR-recruiting guide RNAs or ASOs (PCT\/EP2024\/051033), and RP, BC, AA, and FNP on a separate application covering the use of\n                      editopes\n                      . The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}